Biosimilars are emerging class of medications that are very similar to biologics (in terms of safety and efficacy to the original reference product); but not the same as generic. originating. or reference drugs. The availability and use of biosimilars in oncology landscape are slowly picking. https://www.sukrensi.com/flash-sale-Ribavirin-500MG-R0077-500MG-p9633-big-savings/